May 7th 2024
In patients with Clostridium difficile infection (CDI), ibezapolstat was shown to have similar results to a standard of care therapy.
Prior Hospitalizations Associated With Readmission with CDI
November 1st 2020A third of patients hospitalized with community-onset Clostridioides difficile infections had recently been discharged from the same hospital, and most of those received antibiotics, according to research presented at IDWeek.
Read More
Positive Topline Data From Phase 3 C diff Trial
August 11th 2020Administration of the investigational oral microbiome therapeutic SER-109 resulted in a statistically significant decrease in the proportion of patients who had C diff recurrence within 8 weeks of administration versus placebo.
Read More
Developing a Risk Prediction Model for Health Care-Associated C Diff Infection
December 16th 2019A team of investigators set out to identify whether a risk prediction model that was developed at Novant Health could accurately identify individuals at a high-risk for health care-associated C diff infection.
Read More
Get Off the SOFA! Introducing the Quick Pitt Bacteremia Score
The quick Pitt Bacteremia Score offers accuracy comparable to the original version's across multiple infections, and maintains ease of use.
Read More